Access and Evidence
Merck Settles Vytorin Clinical Trials Data Lawsuit For US$688 Million
In what is claimed to be one of the top 25 securities class action settlements of all time, Merck & CO has settled investor claims that the company withheld negative data from clinical trials on Vytorin.